DermaSensor announced today that it raised $16 million in a Series B funding round to fuel its commercial expansion efforts.
Scientists have created a new light-based cancer therapy that targets tumors precisely without harming healthy cells.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback